The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (Q41191925)
Jump to navigation
Jump to search
scientific article published on June 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase |
scientific article published on June 1996 |
Statements
1 reference
The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (English)
1 reference
Berkhout TA
1 reference
Simon HM
1 reference
Patel DD
1 reference
Bentzen C
1 reference
Niesor E
1 reference
Jackson B
1 reference
Suckling KE
1 reference
1 June 1996
1 reference
1 reference
14376-14382
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference